Lianhe Chemical Technology Co., Ltd. Class A

Lianhe Chemical Technology Co., Ltd. Class A

SSZSE:002250
13.37
CNY
+0.13
(+0.98%)
12.30BMarket Cap
Oct 27Next Earn
Lianhe Chemical Technology Co., Ltd. Class A
SZSE:002250
(Shenzhen Stock Exchange)

Recent

price

13.37

P/E

ratio

- -

div

yld

0.92%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.69
3.37
3.83
4.27
5
4.84
3.76
4.42
4.38
4.75
5.21
7.1
8.47
6.92
6.15
7.06
- -
Revenue per Share
0.28
0.39
0.47
0.57
0.69
0.77
0.32
0.22
0.04
0.16
0.12
0.34
0.75
-0.5
0.11
0.4
- -
Basic EPS, GAAP
-0.18
-0.51
-0.27
-0.42
-0.22
0.19
0.31
0.09
-0.16
-0.07
-0.09
-0.98
-1.18
0.02
0.71
0.78
- -
Free Cash Flow per Basic Share
0.07
0.09
0.07
0.14
0.16
0.19
0.19
0.17
0.19
0.15
0.14
0.13
0.13
0.28
0.16
0.15
0.12
Dividend per Share
1.23
2.29
2.73
3.4
4.08
4.96
5.21
6.08
6.14
6.39
6.53
6.83
7.53
6.98
7.1
7.46
7.69
Book Value per Share
1.15
2.19
2.57
3
3.58
4.47
4.87
5.07
5.27
5.72
5.93
6.26
6.97
6.44
6.52
6.71
6.95
Tangible Book Value per Share
733
761
773
789
799
829
825
930
938
902
917
928
929
930
923
910
900
Basic Weighted Avg Shares
1,973
2,568
2,955
3,368
3,990
4,008
3,099
4,107
4,114
4,284
4,782
6,587
7,865
6,442
5,677
6,430
- -
Sales/Revenue/Turnover
13.37
13.8
15.87
16.72
17.54
18.69
9.82
7.51
6.99
13.81
12.84
9.69
10.72
1.05
8.07
9.17
- -
Operating Margin (%)
59
68
103
149
183
252
317
373
411
446
480
571
594
775
771
880
- -
Depreciation Expense
203
294
366
450
551
638
264
205
38
144
110
315
697
-465
103
362
- -
Net Income, GAAP
18.19
14.06
16.64
14.03
14.88
12.43
13.24
18.7
48.84
36.84
36.19
22.52
22.05
- -
37.22
10.93
- -
Effective Tax Rate (%)
10.29
11.46
12.37
13.35
13.81
15.92
8.51
4.98
0.91
3.37
2.3
4.79
8.86
-7.22
1.82
5.63
- -
Profit Margin (%)
-22
472
635
548
435
927
1,176
1,947
793
1,354
869
126
763
1,499
1,182
1,043
1,540
Working Capital
8
8
622
623
624
625
627
1,560
8
215
664
694
1,550
2,821
2,276
1,442
1,618
LT Debt
883
1,816
2,134
2,706
3,371
4,182
4,394
5,660
5,720
5,971
6,068
6,329
7,218
6,758
6,876
7,133
7,368
Total Equity
19.32
17.13
13.8
13.5
13.97
13.2
4.17
3.61
0.93
2.83
1.84
4.23
5.18
- -
1.51
4.27
- -
Return on Invested Capital (%)
19.68
17.36
14.75
13.78
14.01
13.44
5.84
4.17
0.94
1.88
1.78
4.37
7.45
- -
1.18
3.83
- -
Return on Capital (%)
25.24
22.14
18.82
18.78
18.33
17.08
6.22
4.1
0.66
2.49
1.84
5.12
10.52
-6.95
1.6
5.49
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,562
1,894
1,783
LT Borrowings
1,429
1,446
1,606
LT Finance Leases
14
13
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
900
900
900
Market Capitalization
12,040
14,902
12,301

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,783
6,141
6,652
Cash, Cash Equivalents & STI
666
594
1,262
Accounts Receivable, Net
1,657
2,248
2,127
Inventories
2,756
2,504
2,588
Total Current Liabilities
4,741
4,945
5,112
Payables & Accruals
- -
- -
- -
ST Debt
1,562
1,894
1,783
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.84%
3.49%
3.73%
Free Cash Flow
346.19%
754.02%
8.37%
Net Income, GAAP
36.74%
53.92%
250.93%
Sales/Revenue/Turnover
6.62%
8.09%
13.27%
Total Cash Common Dividend
4.13%
11.87%
-9.29%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,466
1,512
1,381
1,318
5,677
2025
1,510
1,640
- -
1,712
6,430
2026
1,963
2,032
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.02
0.08
0.11
2025
0.05
0.19
- -
0.05
0.4
2026
0.11
0.3
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.03
0.05
0.05
0.16
2025
0.04
0.03
- -
0.03
0.15
2026
0.03
0.07
- -
- -
- -
Business
Lianhe Chemical Technology Co., Ltd. Lianhe Chemical Technology Co., Ltd. (002250.SZ) is a China-based company principally engaged in the research, development, production, and sale of chemical products, with core operations spanning plant protection, pharmaceuticals, functional chemicals, and engineering technology services. The company offers crop protection products including herbicides, insecticides, fungicides, and plant growth regulators; pharmaceutical intermediates and active pharmaceutical ingredients; performance and functional chemicals such as fine chemicals, plastic additives, and specialty intermediates like dichlorobenzonitriles and chlorobenzonitriles; as well as custom manufacturing services, process engineering, and equipment for the pharmaceutical, agrochemical, and industrial sectors. Founded in 1985 and headquartered in Taizhou, Zhejiang Province, China, it primarily serves domestic markets with expanding international presence in Europe and Asia, employing over 5,000 staff and operating production facilities including recent expansions in Malaysia and the UK. In recent developments, the company announced plans in November 2024 to invest up to USD200 million via its Singapore unit in a three-phase manufacturing facility in Johor, Malaysia, for pesticide and pharmaceutical intermediates, new energy chemicals, enhancing global competitiveness through lower costs and tax incentives; completed the acquisition of Fine Industries Limited, including subsidiaries Fine Organics Ltd. and Fine Environmental Services in the UK, to support European expansion in crop protection and performance chemicals; and executed a share repurchase program closing in March 2025, acquiring 1.26% of its shares for CNY 80 million to optimize capital structure.